CAS: 804-30-8; N-((4-Amino-2-Methylpyrimidin-5-yl)Methyl)-N-(5-Hydroxy-3-(((Tetrahydrofuran-2-yl)Methyl)Disulfanyl)Pent-2-En-2-yl)Formamide

上下游产品

Thiamine hydr°Chloride

专利信息

专利号:US-2005182036-A1
优先权日:2002-08-02
标题:Medicinal composition containing an HMG-CoA reductase inhibitor
发明人：KONDO TATSUHITO; TAKAGI IKUO; NAKAYAMA MASATO; TORIZUMI YASUHIRO
权利人:SANKYO CO
摘要:A pharmaceutical composition for promoting the synthesis of vascular endothelial nitrogen oxide and/or maintaining or elevating the concentration of vascular endothelial nitrogen oxide in the blood, or a pharmaceutical composition for improving blood lipids. The pharmaceutical composition contains an HMG-CoA reductase inhibitor; and gamma-oryzanol, and/or thiamines. For treatment, the components of the composition can be administered together, as a composition, or separately.

专利号:WO-2004012740-A1
优先权日:2002-08-02
标题 :MEDICINAL COMPOSITION CONTAINING HMG-CoA REDUCTASE INHIBITOR
发明人：KONDO TATSUHITO; TAKAGI IKUO; NAKAYAMA MASATO; TORIZUMI YASUHIRO
权利人:SANKYO CO; KONDO TATSUHITO; TAKAGI IKUO; NAKAYAMA MASATO; TORIZUMI YASUHIRO
摘要:[Problem] To provide a medicinal composition for promoting the synthesis of vascular endothelial nitrogen oxide and/or maintaining or elevating the concentration of vascular endothelial nitrogen oxide in the blood, or a medicinal composition for improving blood lipids. [Means for Resolution] A medicinal composition which contains an HMG-CoA reductase inhibitor, Ïœ-oryzanol and/or thiamines.

专利号:CN-117466877-A
优先权日:2023-10-11
标 题:A kind of synthesis method of furthiamine hydrochloride